RESEARCH: New study suggests means to control chemotherapy's side effects | News | Notre Dame News | University of Notre Dame






	
	





  	Skip To Content
	Skip To Navigation
	Skip To Search






  
  
    University of Notre Dame

    
      
      Notre Dame News

      
      
    


    
    
      
        
        
        	
	Experts
	ND in the News
	Subscribe
	About Us
	


      
        
          
          
          
          
          
        

      


      
    


    
    
      	 Home
	 Contact
	 Search
	
          
          
            
            
          
          Menu
        
        


      
        
          
          
          
          
          
        

      

    

  

  
  

  

  
    	Home › 
	News › 
	RESEARCH: New study suggests means to control chemotherapy's side effects


    
      
        
          RESEARCH: New study suggests means to control chemotherapy's side effects

          
            
              
                
                Published: June 07, 2004
              

              
                Author: William G. Gilroy
              

              







          

          
          
          

          
        
        
        
          

Since the mid-1990s, a drug called olanzapine has been used to treat schizophrenia and other psychoses.p. Now, a team of scientists led by a University of Notre Dame cancer researcher has found a new use for the drug that may make chemotherapy treatments far less onerous.p. Rudolph M. Navari, director of Notre Dame’s Walther Cancer Research Center, led a team of researchers from the Indiana University and University of Kentucky Medical Schools and the Walther Cancer Institute’s Hoosier Oncology Group in a study of the use of olanzapine for the control of chemotherapy-induced nausea and vomiting. The study demonstrated that olanzapine, which carries the brand name Zyprexa, was very effective in preventing the common and feared side effects in patients receiving various types of chemotherapy.p. When olanzapine was added to the standard mix of drugs used to relieve nausea and vomiting given to patients prior to receiving chemotherapy, there was essentially no nausea or vomiting in the 24-hour period following treatment. Olanzapine also prevented nausea and vomiting during the week after chemotherapy if it was given daily for two to five days.p. Olanzapine is currently FDA-approved to treat various psychoses, such as schizophrenia. It also has been used recently to control nausea induced by opioids (opium-based drugs). The Navari study, however, is the first demonstration of olanzapine’s effectiveness in patients receiving chemotherapy treatments.p.

TopicID: 5560

        

        
        
          
            

          

        
      
      
    
  
  
    	Home
	Experts
	ND in the News
	Subscribe
	About Us


  

  
  
    
     
  
  

  
  
    
      	For the Media
	Contact


    
            
    
      
	Office of Public Affairs and Communications


      Notre Dame News

      
        
          
            500 Grace Hall
 
            Notre Dame, IN 46556 USA
          
          
          
          
        

        
          	 Facebook
	 Twitter
	 Instagram
	 YouTube
	 Pinterest


        
      

      
© 2022 University of Notre Dame

    
    
      

        
      
      
        
          	Search
	Mobile App
	News
	Events
	Visit
	Accessibility


        
        
          	 Facebook
	 Twitter
	 Instagram
	 YouTube
	 LinkedIn